Synera Advisory to Present at Venture Summit West on De-Risking MedTech and HealthTech Investments

Synera Advisory will present at Venture Summit West on reducing commercialization risk in MedTech and HealthTech innovation.

United States, May 20, 2026 -- Synera Advisory, a physician-backed commercialization and strategic advisory firm focused on MedTech, digital health, and healthcare innovation, today announced that founder and strategic partnerships leader Jordan Morrison will present at the Life Sciences & Healthcare Track during Venture Summit West, addressing one of the most pressing challenges facing investors and early-stage healthcare companies: systematically de-risking MedTech and HealthTech innovation while increasing enterprise value and investor confidence.

Featured Session

“From Concept to Commercialization: De-Risking MedTech & HealthTech to Accelerate Valuation and Investment Readiness”

The presentation will equip founders, venture capital firms, strategic investors, and healthcare innovators with practical frameworks for identifying and mitigating the most common commercialization risks that delay adoption, reduce valuation, or impede successful fundraising.

Key Discussion Areas

The presentation will equip founders, venture capital firms, strategic investors, and healthcare innovators with practical frameworks for identifying and mitigating the most common commercialization risks that delay adoption, reduce valuation, or impede successful fundraising. The session will focus on operational, regulatory, and market adoption strategies that can strengthen investor confidence while improving long term scalability and commercialization readiness for emerging healthcare companies.

• Regulatory and reimbursement strategy as valuation drivers
• FDA pathway readiness and commercialization alignment
• Market validation through physician and stakeholder engagement
• Health economic modeling and VAC preparedness
• Go-to-market infrastructure for scalable growth
• Clinical adoption strategy and KOL ecosystem development
• Common diligence gaps that increase investor risk exposure
• Building investor-ready healthcare companies before Series A

“Many healthcare startups focus almost exclusively on product innovation while underestimating commercialization risk. Our mission is to help founders and investors build companies that are not only innovative, but operationally credible, clinically validated, reimbursement-aware, and positioned for scalable adoption. De-risking is what ultimately drives stronger valuations and sustainable growth.”

• Jordan Morrison, Founder & Strategic Partnerships Lead, Synera Advisory

Event Details

Venture Summit West will take place on June 16 and 17, 2026, in Silicon Valley, California. The event’s Life Sciences & Healthcare Track is expected to host more than 140 venture capital firms and institutional investors focused on healthcare innovation, MedTech, digital health, and emerging healthcare technologies.

About Synera Advisory

Synera Advisory is a physician-backed healthcare commercialization and strategic advisory firm specializing in MedTech, digital health, healthcare SaaS, and clinical innovation. The firm partners with founders, investors, and healthcare organizations to accelerate commercialization, reduce operational and regulatory risk, improve investor readiness, and support scalable growth strategies across the healthcare ecosystem.

The firm’s ecosystem includes experienced physicians, commercialization leaders, reimbursement strategists, regulatory consultants, healthcare operators, and investor-facing advisors who collectively support companies from concept through post-commercialization scaling.

Additional information is available at the website Synera Advisory and on LinkedIn. Media inquiries may be directed to j.morrison@syneraadvisory.org.

Contact Info:
Name: Jordan Morrison
Email: Send Email
Organization: Synera Advisory
Website: https://syneraadvisory.org/

Release ID: 89192420

Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.